13F filer · CIK 1037792 ↗

Paradigm Capital Management Inc

You are looking at Q1 2025. See the latest, Q2 2026 →

Reported value

$1.80B

−17% on the quarter before

Positions

127

7 new · 8 sold out

Top 10

50.7%

of the value

Est. gain

−$319.9M

on stocks held all quarter

Est. return

−15.7%

on those stocks since Q4 2024

Filed

May 15, 2025

On SEC EDGAR ↗

Positions as of Mar 31, 2025, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.

103 others22%
Broadcom7.5%Onto Innovation7.4%Modine7.0%
Fabrinet5.8%
Insight Enterprises5.0%
Jabil4.3%Globus Medical3.9%
Extreme Networks3.8%
Ducommun Inc3.3%
Veeco Instruments2.7%
Entegris2.6%
Ensign Group, Inc.2.5%
Enersys2.5%
Concentrix Corp2.3%
Orthofix Medical Inc.2.2%
Ribbon Communications Inc2.1%
Calix Inc2.0%
Mimedx2.0%
Integra Lifesciences Holdings Corp1.7%
Enovis Corporation1.7%
Enviri Corp1.7%
Pennant Group Inc.1.3%
American Woodmark Corporation1.2%
Tactile Systems Technology1.1%

Largest buys

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Quidel Corp~$14.0MAdded · 0.1% → 0.9%+399,500 shares
  2. Penguin Solutions Inc~$13.4MAdded · 0.3% → 1.1%+769,200 shares
  3. Enovis Corporation~$9.7MAdded · 1.1% → 1.7%+253,200 shares
  4. Veeco Instruments~$8.0MAdded · 2.5% → 2.7%+397,200 shares
  5. FormFactor~$7.3MAdded · 0.1% → 0.5%+257,600 shares
  6. Semtech~$6.6MNew · 0.0% → 0.4%+191,600 shares
  7. Orthopediatrics Corp~$4.0MAdded · 0.0% → 0.2%+160,700 shares
  8. American Woodmark Corporation~$3.3MAdded · 1.1% → 1.2%+55,711 shares
  9. Revvity Inc.~$2.6MAdded · 0.1% → 0.2%+25,000 shares
  10. Ultra Clean Holdings Inc~$2.1MAdded · 1.1% → 0.9%+100,000 shares

Largest sells

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Summit Materials, Inc. Class A~$42.9MSold out · 2.0% → 0.0%−847,890 shares
  2. Adtran Inc~$20.4MCut · 0.9% → 0.0%−2,339,600 shares
  3. Smurfit Westrock L~$12.6MCut · 0.9% → 0.2%−280,700 shares
  4. Kratos Defense~$7.5MCut · 0.7% → 0.5%−252,300 shares
  5. Ducommun Inc~$3.9MCut · 3.2% → 3.3%−66,900 shares
  6. Angiodynamics, Inc.~$3.7MSold out · 0.2% → 0.0%−404,001 shares
  7. Ocular Therapeutix Inc.~$3.4MSold out · 0.2% → 0.0%−400,000 shares
  8. Eton Pharmaceuticals, Inc.~$2.7MSold out · 0.1% → 0.0%−200,000 shares
  9. Ribbon Communications Inc~$2.5MCut · 2.0% → 2.1%−627,421 shares
  10. Citi Trends, Inc.~$2.1MCut · 0.2% → 0.1%−92,972 shares

Holdings

As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
BroadcomCOM · shares 0% · price −27.8%7.5%$135.5M−$52.1M
Onto InnovationCOM · shares 0% · price −27.2%7.4%$134.1M−$50.1M
ModineCOM · shares −0.05% · price −33.8%7.0%$126.4M−$64.5M
FabrinetCOM · shares −0.08% · price −10.2%5.8%$105.0M−$11.9M
Insight EnterprisesCOM · shares 0% · price −1.4%5.0%$89.4M−$1.3M
JabilCOM · shares −0.3% · price −5.4%4.3%$77.7M−$4.5M
Globus MedicalCOM · shares 0% · price −11.5%3.9%$69.5M−$9.0M
Extreme NetworksCOM · shares +0.7% · price −21.0%3.8%$69.1M−$18.2M
Ducommun IncCOM · shares −6.2% · price −8.8%3.3%$59.0M−$5.7M
Veeco InstrumentsCOM · shares +20% · price −25.1%2.7%$47.8M−$13.3M
EntegrisCOM · shares 0% · price −11.7%2.6%$46.9M−$6.2M
Ensign Group, Inc.COM · shares +0.2% · price −2.6%2.5%$44.9M−$1.2M
EnersysCOM · shares +1.1% · price −0.9%2.5%$44.3M−$406,276
Concentrix CorpCOM · shares −0.3% · price +28.6%2.3%$41.6M+$9.3M
Orthofix Medical Inc.COM · shares −0.2% · price −6.6%2.2%$40.5M−$2.9M
Ribbon Communications IncCOM · shares −6.2% · price −5.8%2.1%$37.3M−$2.3M
Calix IncCOM · shares −2.8% · price +1.6%2.0%$36.4M+$585,561
MimedxCOM · shares −0.06% · price −21.0%2.0%$35.6M−$9.5M
Integra Lifesciences Holdings CorpCOM · shares −3.2% · price −3.0%1.7%$30.5M−$955,788
Enovis CorporationCOM · shares +47% · price −12.9%1.7%$30.0M−$3.0M
Enviri CorpCOM · shares −0.1% · price −13.6%1.7%$29.7M−$4.7M
Pennant Group Inc.COM · shares +1.7% · price −5.2%1.3%$24.0M−$1.3M
American Woodmark CorporationCOM · shares +18% · price −26.0%1.2%$21.0M−$6.2M
Tactile Systems TechnologyCOM · shares −8.0% · price −22.8%1.1%$20.2M−$6.0M
CerenceCOM · shares −2.0% · price +0.6%1.1%$20.1M+$127,110
Total · 127 positions100%$1.80B−$319.9M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2024 to Q1 2025: 120 stocks held throughout, down $319.9M (−15.7%).

  1. Concentrix Corp+$9.3M+29%
  2. Xerox Corp25:1 split+$5.6M+1,332%
  3. Cohu Inc.2:1 split+$1.3M+10%
  4. Kratos Defense+$1.0M+13%
  5. Johnson & Johnson+$609,014+15%
  6. Veeco Instruments−$13.3M−25%
  7. Extreme Networks−$18.2M−21%
  8. Onto Innovation−$50.1M−27%
  9. Broadcom−$52.1M−28%
  10. Modine−$64.5M−34%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$4.00B$2.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$3.67B+41%SEC ↗
Q1 2026$2.61B+10%SEC ↗
Q4 2025$2.38B+3%SEC ↗
Q3 2025$2.31B+12%SEC ↗
Q2 2025$2.05B+14%SEC ↗
Q1 2025$1.80B−17%SEC ↗
Q4 2024$2.16B−4%SEC ↗
Q3 2024$2.25B+3%SEC ↗
Q2 2024$2.19B+5%SEC ↗
Q1 2024$2.09B+9%SEC ↗
Q4 2023$1.92B+10%SEC ↗
Q3 2023$1.74B−0%SEC ↗
Q2 2023$1.75B+16%SEC ↗
Q1 2023$1.51B−0%SEC ↗
Q4 2022$1.51B+9%SEC ↗
Q3 2022$1.39B−6%SEC ↗
Q2 2022$1.47B−20%SEC ↗
Q1 2022$1.85B−17%SEC ↗
Q4 2021$2.24B+15%SEC ↗
Q3 2021$1.94B−7%SEC ↗
Q2 2021$2.08B+8%SEC ↗
Q1 2021$1.93B+15%SEC ↗
Q4 2020$1.67B+41%SEC ↗
Q3 2020$1.19B+9%SEC ↗
Q2 2020$1.09B+32%SEC ↗
Q1 2020$827.9M−36%SEC ↗
Q4 2019$1.30B+16%SEC ↗
Q3 2019$1.12B+2%SEC ↗
Q2 2019$1.10B−4%SEC ↗
Q1 2019$1.14B+12%SEC ↗
Q4 2018$1.02B−20%SEC ↗
Q3 2018$1.27B+3%SEC ↗
Q2 2018$1.24B+5%SEC ↗
Q1 2018$1.18B+1%SEC ↗
Q4 2017$1.17B+2%SEC ↗
Q3 2017$1.15B+4%SEC ↗
Q2 2017$1.11B+5%SEC ↗
Q1 2017$1.06B+3%SEC ↗
Q4 2016$1.03B+8%SEC ↗
Q3 2016$953.0M+16%SEC ↗
Q2 2016$820.6M−4%SEC ↗
Q1 2016$858.8MSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.